2022 annual financial data
Silence Therapeutics 2022 Operating margin
Silence Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -281.87%.
Operating income was -49,759,502 GBP and net income was -41,032,025 GBP.
Operating cash flow was -57,044,000 GBP.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,653,047 GBP
- Operating income
- -49,759,502 GBP
- Net income
- -41,032,025 GBP
- Operating cash flow
- -57,044,000 GBP